$1.1B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | DNTH Dianthus Therapeutics Inc | 1.8M | −5.4% | $180M | 16.1% |
| 2 | DFTX Definium Therapeutics Inc | 3.0M | +20.9% | $139M | 12.5% |
| 3 | ABIVAX SA Abivax Sa | 993,000 | +46.7% | $132M | 11.9% |
| 4 | COGT Cogent Biosciences Inc | 2.4M | +0.0% | $91M | 8.2% |
| 5 | ALMS Alumis Inc | 2.8M | +0.0% | $80M | 7.2% |
| 6 | AVBP Arrivent Biopharma Inc | 2.0M | +0.0% | $68M | 6.2% |
| 7 | TSHA Taysha Gene Therapies Inc | 9.7M | +9.4% | $66M | 5.9% |
| 8 | BIOA Bioage Labs Inc | 1.7M | +0.0% | $43M | 3.9% |
| 9 | MIRM Mirum Pharmaceuticals Inc | 338,900 | +0.0% | $40M | 3.6% |
| 10 | KYMR Kymera Therapeutics Inc | 310,000 | −27.1% | $36M | 3.2% |
| 11 | AKTS Aktis Oncology Inc | 960,847 | +0.0% | $31M | 2.8% |
| 12 | XENE Xenon Pharmaceuticals Inc | 490,000 | +0.0% | $30M | 2.7% |
| 13 | PALI Palisade Bio Inc | 10.3M | +0.0% | $21M | 1.9% |
| 14 | OCUL Ocular Therapeutix Inc | 2.1M | −34.5% | $20M | 1.8% |
| 15 | IRON Disc Medicine Inc | 270,000 | +0.0% | $20M | 1.8% |
| 16 | SMMT Summit Therapeutics Inc | 1.2M | — | $18M | 1.6% |
| 17 | PHVS Pharvaris N V | 456,721 | +176.8% | $16M | 1.4% |
| 18 | ANL Adlai Nortye Ltd | 934,716 | — | $11M | 1.0% |
| 19 | DTIL Precision Biosciences Inc | 1.4M | −39.6% | $11M | 1.0% |
| 20 | DBVT Dbv Technologies S A | 574,200 | +0.0% | $9M | 0.8% |
| 21 | FTH Faeth Therapeutics Inc | 361,010 | — | $9M | 0.8% |
| 22 | GYRE Gyre Therapeutics Inc | 954,416 | — | $6M | 0.6% |
| 23 | TRVI Trevi Therapeutics Inc | 315,000 | −78.8% | $6M | 0.5% |
| 24 | UNCY Unicycive Therapeutics Inc | 1.0M | +0.0% | $5M | 0.4% |
| 25 | CNTX Context Therapeutics Inc | 3.0M | −41.9% | $2M | 0.2% |
| 26 | GOSS Gossamer Bio Inc | 7.8M | +0.0% | $1M | 0.1% |